30
Jan
Justicia Shipena The Ministry of Health and Social Services has approved the registration of lenacapavir. Lenacapavir is a long-acting HIV prevention medicine administered twice a year. Lenacapavir is used as pre-exposure prophylaxis (PrEP) and is given as an injectable formulation. This differs from existing PrEP options, which require people to take tablets every day. Thousands of Namibians are currently using daily oral PrEP. Namibia has surpassed the 95-95-95 HIV targets set by UNAIDS. These targets require that 95% of people living with HIV know their status, 95% of those diagnosed receive treatment, and 95% of those on treatment achieve viral…
